Deloitte has recently acquired Gryphon Scientific to expand its biosafety, biosecurity, public health, and emergency preparedness and response capabilities. As part of the acquisition, Deloitte will integrate Gryphon’s team of scientists, programmers, data analysts, public health specialists, and planning and policy professionals with expertise in scientific communications, modeling, data science, and risk assessment.
The collaboration between the two companies will focus on developing artificial intelligence applications through Deloitte’s Federal Health AI Accelerator. These applications will aim to enhance public health and safety measures and assist clients in preparing for chemical threats, biothreats, and other biological emergencies.
Beth Meagher, who serves as the U.S. federal health sector leader and principal at Deloitte Consulting, expressed enthusiasm about the addition of Gryphon’s professionals and leadership to the consulting firm. She emphasized that this move enhances Deloitte’s data analytics and advanced tech capabilities and will enable them to support federal agencies in safeguarding national security and public health.
Meagher added that their federal health practice is committed to leading the way for U.S. government and public services (GPS) by leveraging AI-enabled, data-driven technology and scientific expertise. This will ultimately strengthen their ability to help government leaders protect the nation and ensure the health and safety of its citizens.
In summary, Deloitte’s acquisition of Gryphon Scientific is aimed at expanding its capabilities in biosafety, biosecurity, public health, emergency preparedness response while integrating expertise in scientific communications